News

GLP-1s are revolutionary drugs in the treatment of obesity, but they're very expensive, and this creates a real barrier to people who need access to these drugs.
Our formulary strategy is centered around providing cost-effective, clinically appropriate prescription coverage We remove barriers to care, increase access to new treatments and make them more ...